Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension

Paul Bhamra-Ariza; Anne M Keogh; David W M Muller

doi:10.1016/j.jacc.2013.11.022

Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension

J Am Coll Cardiol. 2014 Feb 25;63(7):611-618. doi: 10.1016/j.jacc.2013.11.022. Epub 2013 Dec 11.

Authors

Paul Bhamra-Ariza¹, Anne M Keogh², David W M Muller³

Affiliations

¹ St. Vincent's Hospital, Sydney, New South Wales, Australia; St. George's Hospital, London, United Kingdom.
² St. Vincent's Hospital, Sydney, New South Wales, Australia.
³ St. Vincent's Hospital, Sydney, New South Wales, Australia. Electronic address: dmuller2@me.com.

PMID: 24315895
DOI: 10.1016/j.jacc.2013.11.022

Abstract

Despite improvements in medical therapy, the overall prognosis of patients with severe pulmonary arterial hypertension remains poor. Heart-lung transplantation or bilateral lung transplantation is the final pathway for a minority. This paper describes both established and novel percutaneous interventional techniques that may palliate or bridge pulmonary hypertension patients to transplantation.

Keywords: intervention; percutaneous; pulmonary hypertension.

Publication types

Review

MeSH terms

Humans
Hypertension, Pulmonary / diagnosis*
Hypertension, Pulmonary / surgery*
Percutaneous Coronary Intervention / methods*
Percutaneous Coronary Intervention / trends
Severity of Illness Index*
Treatment Outcome